Skip to main content

Peer Review reports

From: A multicentre, prospective, non-interventional study evaluating the safety of dapagliflozin in patients with type 2 diabetes in routine clinical practice in China (DONATE)

Original Submission
19 Oct 2022 Submitted Original manuscript
3 Dec 2022 Reviewed Reviewer Report
9 Dec 2022 Reviewed Reviewer Report
19 Dec 2022 Reviewed Reviewer Report
20 Dec 2022 Reviewed Reviewer Report
17 Feb 2023 Author responded Author comments - Lixin Guo
Resubmission - Version 2
17 Feb 2023 Submitted Manuscript version 2
23 Feb 2023 Reviewed Reviewer Report
16 Mar 2023 Reviewed Reviewer Report
16 May 2023 Author responded Author comments - Lixin Guo
Resubmission - Version 3
16 May 2023 Submitted Manuscript version 3
Publishing
24 May 2023 Editorially accepted
14 Jun 2023 Article published 10.1186/s12916-023-02906-7

You can find further information about peer review here.

Back to article page